Venus Concept Free Cash Flow Per Share Over Time
| VERO Stock | USD 2.65 0.12 4.33% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Venus Concept Performance and Venus Concept Correlation. Venus |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Venus Concept. If investors know Venus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Venus Concept listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (87.67) | Revenue Per Share | Quarterly Revenue Growth (0.15) | Return On Assets | Return On Equity |
The market value of Venus Concept is measured differently than its book value, which is the value of Venus that is recorded on the company's balance sheet. Investors also form their own opinion of Venus Concept's value that differs from its market value or its book value, called intrinsic value, which is Venus Concept's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Venus Concept's market value can be influenced by many factors that don't directly affect Venus Concept's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Venus Concept's value and its price as these two are different measures arrived at by different means. Investors typically determine if Venus Concept is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Venus Concept's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Free Cash Flow Per Share Analysis
Compare Venus Concept and related stocks such as Aziyo Biologics, Ainos Inc, and SurModics Free Cash Flow Per Share Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AIMD | (124) | (1.3696) | (1.9171) | (2.636) | (0.7439) | (0.2815) | (0.4982) | (0.3917) | (0.4278) | (1.7343) | (0.9332) | (0.9229) | (1.3401) | (1.1683) | (0.6134) | (0.64) |
| SRDX | 0.1044 | 0.8863 | 1.0886 | 1.1669 | 1.0088 | 1.3059 | 0.5794 | 1.5226 | 0.0963 | 0.7629 | 0.6618 | (1.4798) | 0.5414 | (0.2292) | (0.26) | (0.25) |
| LNSR | (0.4825) | (0.4825) | (0.4825) | (0.4825) | (0.4825) | (0.4825) | (0.4825) | (0.4825) | (0.4825) | (1.3797) | (1.2949) | (0.9946) | (1.4737) | (0.9019) | (0.2111) | (0.22) |
| IRIX | 0.3492 | 0.3176 | 0.519 | 0.519 | 0.519 | 0.519 | (0.1185) | 0.519 | 0.519 | 0.519 | 0.519 | 0.519 | (0.6152) | (0.6152) | (0.71) | (0.67) |
| CVRX | (26.7126) | (26.7126) | (26.7126) | (26.7126) | (26.7126) | (26.7126) | (26.7126) | (26.7126) | (26.7126) | (26.7126) | (42.3863) | (1.3955) | (2.1143) | (1.9133) | (1.7926) | (1.88) |
| INGN | (0.4892) | (0.4892) | (0.5817) | (0.259) | (0.0334) | 1.3234 | 1.147 | 2.4303 | 2.0877 | 1.5617 | 0.8833 | (0.0193) | (2.571) | (1.305) | 0.25 | 0.35 |
| OFIX | 0.2558 | 2.1418 | (0.9257) | 1.9898 | 1.757 | 0.8154 | 1.4535 | 2.0087 | 1.8742 | 0.6088 | 2.9675 | (0.0567) | (1.7303) | (2.9351) | (0.2383) | (0.23) |
| ESTA | (1.3426) | (1.3426) | (1.3426) | (1.3426) | (1.3426) | (1.3426) | (1.3426) | (2.1968) | (2.0551) | (1.8004) | (0.7041) | (1.4292) | (3.5339) | (4.4164) | (2.316) | (2.43) |
| NPCE | (1.0699) | (1.0699) | (1.0699) | (1.0699) | (1.0699) | (1.0699) | (1.0699) | (1.0699) | (1.0699) | (1.0699) | (0.9095) | (1.0208) | (1.5236) | (0.7688) | (0.6162) | (0.65) |
| SGHT | (0.4672) | (0.4672) | (0.4672) | (0.4672) | (0.4672) | (0.4672) | (0.4672) | (0.4672) | (0.4672) | (0.5489) | (0.7084) | (1.1231) | (1.6079) | (0.9866) | (0.4535) | (0.48) |
| SSKN | (52.9461) | (34.5492) | (41.2546) | (287) | (167) | (48.4719) | (7.7548) | 3.6385 | 0.4174 | (0.1757) | (0.0187) | (0.63) | (1.3425) | (1.5859) | (1.43) | (1.5) |
| BBLG | (0.0049) | (31.9633) | (63.7496) | (63.7496) | (63.7496) | (63.7496) | (63.7496) | (63.7496) | (63.7496) | (63.7496) | (8.3712) | (28.5718) | (75.8918) | (36.3153) | (2.7187) | (2.85) |
| BJDX | (21.3784) | (21.3784) | (21.3784) | (21.3784) | (21.3784) | (21.3784) | (21.3784) | (21.3784) | (21.3784) | (21.3784) | (6.4119) | (34.9298) | (70.9457) | (65.7953) | (75.66) | (79.45) |
| NUWE | (386) | (2.2 B) | (1.6 B) | (1.2 B) | (1.2 B) | (1.1 B) | (737.6 M) | (26.9 M) | (3.8 M) | (727.5 K) | (35.8 K) | (9.2 K) | (3.1 K) | (324) | (7.2714) | (7.63) |
| HSCS | (116) | (116) | (116) | (116) | (116) | (116) | (116) | (116) | (116) | (116) | (74.024) | (110) | (72.8493) | (17.5748) | (15.82) | (16.61) |
| AXDX | 2.0025 | (0.7318) | (2.9007) | (2.9007) | (4.749) | (8.6186) | (10.8856) | (10.8579) | (12.6168) | (11.948) | (9.2405) | (7.7642) | (5.9982) | (3.3046) | (3.8) | (3.99) |
| ANIK | (0.6056) | 0.6715 | 0.682 | 1.7551 | 2.6179 | 1.9981 | 0.6666 | 2.184 | 2.0954 | 2.4204 | 0.8042 | 0.226 | (0.2113) | (0.4923) | (0.44) | (0.42) |
| AXGN | 0.11 | (1.9389) | (0.7926) | (0.7918) | (0.6233) | (0.5218) | (0.4037) | (0.316) | (0.659) | (3.6067) | (0.8062) | (1.0143) | (0.8868) | (0.4812) | 2.0E-4 | 3.0E-4 |
Venus Concept and related stocks such as Aziyo Biologics, Ainos Inc, and SurModics Free Cash Flow Per Share description
The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.My Equities
My Current Equities and Potential Positions
| Venus Concept | VERO |
| Classification | Medical Equipment |
| Location | Ontario; Canada |
| Exchange | NASDAQ Exchange |
USD 2.65
Check out Venus Concept Performance and Venus Concept Correlation. To learn how to invest in Venus Stock, please use our How to Invest in Venus Concept guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Venus Concept technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.